Prospective Study - Biobanking.com

Home Tags Prospective Study

Towards A Global Effort: Nightingale To Analyse Mexico City Prospective Study Blood Samples

News Stories David Orchard-Webb, PhD

Founded in 2013, Nightingale Health is a Finnish biotech company aiming to solve the world’s number one health issue - chronic diseases. With a proprietary blood analysis platform, the company can improve risk prediction of diseases such as cardiovascular...

⭐ Recently Featured

Automated Biobanking: Advantages, Benefits and Future Directions

Automated Biobanking: Advantages, Benefits and Future Directions

Ultra-low Temperature Freezers Have Become Important for Today’s Cell and Gene Therapies

Ultra-low Temperature Freezers Have Become Important for Today’s Cell and Gene Therapies

Cryopreservation

Sample lifecycle in a human biobank

Utilizing Modular Biobanking Software in Different Types of Biobanking Activities

Data & Informatics

Meet ISO 20387 Requirements with a Laboratory Software for Biobanking

ISO 20387:2018: The Key to Quality Biobanking

Ethical & Legal & Societal

Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges

Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges

🔥 Popular Posts

Biobank Profiles

10 Largest Biobanks in the World

Biobanking LIMS Softwares

10 Top Laboratory Information Management Systems (LIMS Softwares) for Biobanking

Data & Informatics

Biobank Facilities

Biobank versus Biorepository: What’s in a Name?

Insights & Opinions

Biobanks can comply with regulatory requirements by following ISBER Best Practices.

Biobanking Science: ISBER Best Practices for Biobanks

Biopreservation Science

Biobank Graz

Biobank Profiles

X